Skip to content

A comparative study of normal PET/CT, total body PET/CT, and PET/ enhanced MR in the follow-up after interventional treatment of primary liver cancer

Clinical value of different PET models in primary liver cancer after interventional therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045076
Enrollment
Unknown
Registered
2021-04-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary liver cancer

Interventions

Gold Standard:Pathologic diagnosis
Index test:normal&#32
and&#32
PET/&#32

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years; 2.Primary hepatocellular carcinoma confirmed by imaging, puncture or surgical pathology; 3.Interventional treatment has been performed; 4.Efficacy evaluation needs based on clinical diagnosis and treatment needs: residual and recurrence.

Exclusion criteria

Exclusion criteria: 1.ECOG score 0-1; 2.Diabetic patients with poor blood glucose control; 3.Abnormal preoperative examination: hemoglobin (HGB) 2.5 times the upper limit of normal (ULN), total bilirubin > 2.0 x ULN; Renal function: serum creatinine < 1.5 x ULN; 4.Patients with significantly lower heart, liver, lung, kidney and bone marrow function as assessed by clinicians; 5.Patients with internal metal implantation and unable to perform PET/MR examination; 6.Claustrophobic patients, unable to perform PET/MR; 7.MR enhanced contrast agent allergy; 8.Severe, uncontrolled medical diseases and infections; 9.Unable to cooperate with the developer for other reasons.

Design outcomes

Primary

MeasureTime frame
Objective PET parameters;Subjective evaluation;Consistency;

Countries

China

Contacts

Public ContactFan Wei

Sun Yat-Sen University Cancer Center

fanwei@sysucc.org.cn+86 20 87343049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026